Utah Medical Products Stock Alpha and Beta Analysis
| UTMD Stock | USD 65.29 0.72 1.12% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Utah Medical Products. It also helps investors analyze the systematic and unsystematic risks associated with investing in Utah Medical over a specified time horizon. Remember, high Utah Medical's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Utah Medical's market risk premium analysis include:
Beta 0.87 | Alpha (0.15) | Risk 1.07 | Sharpe Ratio (0.05) | Expected Return (0.05) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Utah |
Utah Medical Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Utah Medical market risk premium is the additional return an investor will receive from holding Utah Medical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Utah Medical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Utah Medical's performance over market.| α | -0.15 | β | 0.87 |
Utah Medical expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Utah Medical's Buy-and-hold return. Our buy-and-hold chart shows how Utah Medical performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Utah Medical Market Price Analysis
Market price analysis indicators help investors to evaluate how Utah Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Utah Medical shares will generate the highest return on investment. By understating and applying Utah Medical stock market price indicators, traders can identify Utah Medical position entry and exit signals to maximize returns.
Utah Medical Return and Market Media
The median price of Utah Medical for the period between Tue, Aug 27, 2024 and Mon, Nov 25, 2024 is 66.27 with a coefficient of variation of 1.89. The daily time series for the period is distributed with a sample standard deviation of 1.25, arithmetic mean of 66.11, and mean deviation of 1.01. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Disposition of 1000 shares by Payne Barbara A of Utah Medical at 90.7 subject to Rule 16b-3 | 09/25/2024 |
| Utah Medical dividend paid on 4th of October 2024 | 10/04/2024 |
2 | Acquisition by Brian Koopman of 500 shares of Utah Medical at 74.64 subject to Rule 16b-3 | 10/17/2024 |
3 | Utah Medical Products GAAP EPS of 3.09, revenue of 31.74M | 10/29/2024 |
4 | Utah Medical Products Inc Reports Q3 2024 EPS of 1.025 Amid 20 percent Revenue Decline | 10/30/2024 |
5 | Acquisition by Brian Koopman of 500 shares of Utah Medical at 64.09 subject to Rule 16b-3 | 11/01/2024 |
6 | Utah Medical Products raises dividend by 1.75 to 0.305 | 11/05/2024 |
7 | With 66 percent institutional ownership, Utah Medical Products, Inc. is a favorite amongst the big guns | 11/07/2024 |
8 | Insider Trading | 11/12/2024 |
9 | FMR LLC Reduces Stake in Utah Medical Products Inc | 11/13/2024 |
10 | Disposition of 1667 shares by Kevin Cornwell of Utah Medical at 107.095 subject to Rule 16b-3 | 11/22/2024 |
About Utah Medical Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Utah or other stocks. Alpha measures the amount that position in Utah Medical Products has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.0314 | 0.008651 | 0.014 | 0.0243 | Price To Sales Ratio | 7.43 | 6.99 | 6.1 | 3.45 |
Utah Medical Upcoming Company Events
As portrayed in its financial statements, the presentation of Utah Medical's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Utah Medical's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Utah Medical's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Utah Medical. Please utilize our Beneish M Score to check the likelihood of Utah Medical's management manipulating its earnings.
| 23rd of April 2024 Upcoming Quarterly Report | View | |
| 31st of March 2024 Next Fiscal Quarter End | View |
Build Portfolio with Utah Medical
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Utah Medical Backtesting, Utah Medical Valuation, Utah Medical Correlation, Utah Medical Hype Analysis, Utah Medical Volatility, Utah Medical History and analyze Utah Medical Performance. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Utah Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.